Mid-Atlantic Retina — Philadelphia, Pennsylvania

Mid-Atlantic Retina is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Mid-Atlantic Retina has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease.

Sponsors: Gyroscope Therapeutics Limited, Eyegate Pharmaceuticals, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Atlantic Retina?

Mid-Atlantic Retina has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Atlantic Retina conducted?

Mid-Atlantic Retina has 6 clinical trials on record, with 1 currently active. Their work covers Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease.

Is Mid-Atlantic Retina accredited by Crixeo Health?

Yes — Mid-Atlantic Retina holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mid-Atlantic Retina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.